Unmetabolized Folic Acid in Prediagnostic Plasma and the Risk for Colorectal Cancer

Journal of the National Cancer Institute

Volumn 107, Issue 12, 2015, Pages

  Cho, Eunyoung ^a,b,c   Zhang, Xuehong ^a   Townsend, Mary K ^a   Selhub, Jacob ^d   Paul, Ligi ^d   Rosner, Bernard ^a,e   Fuchs, Charles S ^f   Willett, Walter C ^a,e   Giovannucci, Edward L ^a,e  

^a CHANNING LABORATORY   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MULTIVITAMIN; VITAMIN D; CYTOSINE; MTHFR PROTEIN, HUMAN; THYMINE;

ADULT; ARTICLE; BIOFORTIFICATION; BLOOD SAMPLING; CALCIUM INTAKE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; ADVERSE EFFECTS; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENT; FORTIFIED FOOD; GENETICS; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOSINE; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; THYMINE;

EID: 85015706375     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv260     Document Type: Article

References (22)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. In. Lyon, France: International Agency for Research on Cancer; 2013.
2. Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011;35(1):2–10.
3. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer. 1999;79(11–12):1917–1922.
4. Martinez ME, Giovannucci E, Jiang R, et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer. 2006;119(6):1440–1446.
5. Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev. 2009;67(4):206–212.
6. Hubner RA, Houlston RS. Folate and colorectal cancer prevention. Br J Cancer. 2009;100(2):233–239.
7. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302(19):2119–2126.
8. Kim YI. Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2220–2225.
9. Wien TN, Pike E, Wisloff T, et al. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open. 2012;2(1):e000653.
10. Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr. 2007;98(4):667–675.
11. Kelly P, McPartlin J, Goggins M, et al. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. 1997;65(6):1790–1795.
12. Kalmbach RD, Choumenkovitch SF, Troen AM, et al. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr. 2008;88(3):763–768.
13. Morris MS, Jacques PF, Rosenberg IH, et al. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr. 2010;91(6):1733–1744.
14. Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136(1):189–194.
15. Colditz GA, Hankinson SE. The Nurses’ Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5(5):388–396.
16. Hankinson SE, Manson JE, Spiegelman D, et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev. 1995;4(6):649–654.
17. Giovannucci E, Rimm EB, Stampfer MJ, et al. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 1994;54(9):2390–2397.
18. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1996;61(44):8781–8797.
19. Hannisdal R, Ueland PM, Svardal A. Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. Clin Chem. 2009;55(6):1147–1154.
20. Kalmbach RD, Choumenkovitch SF, Troen AP, et al. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr. 2008;138(12):2323–2327.
21. Bailey RL, Dodd KW, Gahche JJ, et al. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003–2006. Am J Clin Nutrition. 2010;91(1):231–237.
22. Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370–384.